Pubblicazioni Scientifiche

Ricerca su tutti i campi

Ricerca avanzata

Tipo pubbl.	Pubblicazione
Conference Abstract	Meani P, Cesana F, Giupponi L, Mascolo M, Molteni M, Panzeri F, Vallerio P, Alloni M, Signorini S, Brambilla P, Giannattasio C IL-18, strong predictor of cardiovascular disease and cardiac organ damage High Blood Press Cardiovasc Prev 2014;21(2):166-167.
Conference Abstract	Meani P, Cesana F, Panzeri F, Frigerio L, Giupponi L, Baroni M, Stucchi M, Alloni M, Moreo A, Brambilla P, Signorini S, Giannattasio C IL-18 predicts cardiac organ damage in a population of hypertensive patients Atherosclerosis 2014;235(2):e142- .
Conference Abstract	Meinolf K, Hecht JR, Douillard J-Y, Schwartzberg L, Siena S, Tabernero J, Rivera F, Oliner KS, Yu H, Tian Y, Jung AS, Go WY Extended RAS results from the PRIME and PEAK studies Oncol Res Treat 2014;37(Suppl 5):82- .
Journal Article	Meneghelli A, Alpi A, Cascio MT, Hafner H, Maurer K, Preti A, Raballo A, Cocchi A Italian validation of the Early Recognition Inventory for the retrospective assessment of the Onset of Schizophrenia Checklist: Reliability, validity and instructions for use J Psychopatol 2014;20(2):186-198.
Retrospective Studies; Multicenter Study	Merli M, Visco C, Spina M, Luminari S, Ferretti V V, Gotti M, Rattotti S, Fiaccadori V, Rusconi C, Targhetta C, Stelitano C, Levis A, Ambrosetti A, Rossi D, Rigacci L, D'Arco A M, Musto P, Chiappella A, Baldini L, Bonfichi M, Arcaini L Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: A study on behalf of the Fondazione Italiana Linfomi Haematologica 2014;99(3):489-496.
Comparative Study; Multicenter Study	Minervini A, Siena G, Antonelli A, Bianchi G, Bocciardi AM, Cosciani Cunico S, Ficarra V, Fiori C, Fusco F, Mari A, Martorana G, Medica M, Mirone V, Morgia G, Porpiglia F, Rocco F, Rovereto B, Schiavina R, Simeone C, Terrone C, Volpe A, Carini M, Serni S Open versus laparoscopic partial nephrectomy for clinical T1a renal masses: A matched-pair comparison of 280 patients with TRIFECTA outcomes (RECORd Project) World J Urol 2014;32(1):257-263.
Conference Abstract	Minga P, Meli E, Rusconi C, Zilioli VR, Greco A, Zancanella M, Paris L, Morra E Efficacy and toxicity of brentuximab vedotin monotherapy in relapsed or refractory CD30+ classical hodgkin lymphoma patients outside clinical trials Haematologica 2014;99(Suppl 1):679- .
Research Support; Multicenter Study	Misale S, Arena S, Lamba S, Siravegna G, Lallo A, Hobor S, Russo M, Buscarino M, Lazzari L, Sartore-Bianchi A, Bencardino K, Amatu A, Lauricella C, Valtorta E, Siena S, Di Nicolantonio F, Bardelli A Blockade of EGFR and MEK intercepts heterogeneous mechanisms of acquired resistance to Anti-EGFR therapies in colorectal cancer Sci Transl Med 2014;6(224): 224ra26 .
Journal Article; Research Support	Misale S, Di Nicolantonio F, Sartore-Bianchi A, Siena S, Bardelli A Resistance to anti-EGFR therapy in colorectal cancer: from heterogeneity to convergent evolution Cancer Discov 2014;4(11):1269-1280.
Conference Abstract	Moccia M, Erro R, Mosca L, Cervasio M, Caranci F, Leonardi A, Vitale C, Picillo M, Allocca R, Falco F, Santangelo G, Del Basso-De Caro ML, Penco S, Barone P Hypomorphic NOTCH3 allele in an Italian family with CADASIL features Eur J Neurol 2014;21(Suppl 1):149- .
Conference Abstract	Moccia M, Erro R, Mosca L, Cervasio M, Caranci F, Leonardi A, Vitale C, Picillo M, Allocca R, Falco F, Santangelo G, Del Basso-De Caro ML, Penco S, Barone P Hypomorphic NOTCH3 allele in an Italian family with CADASIL features J Neurol 2014;261(Suppl 1):S106-S107.
Cross-Sectional Studies; Multicenter Study	Modica M, Ferratini M, Spezzaferri R, De Maria R, Previtali E, Castiglioni P Gender differences in illness behavior after cardiac surgery J Cardiopulm Rehabil Prev 2014;34(2):123-129.
Conference Abstract	Molteni A, Borin L, Bernardi M, Pellizzari A, Freyrie A, Della Porta M, Nichelatti M, Ravano E, Riva M, Quaresmini G, Jacopo M, Caramazza D, Ubezio M, Guarco S, Gigli F, Greco R, Morra E The influence of disease and comorbidity risk assessments on the survival of MDS patients treated with 5-azacitidine Haematologica 2014;99(Suppl 1):344- .
Conference Abstract	Molteni A, Riva M, Ravano E, Greco R, Morra E Danazol treatment in lower risk mds patient with severe thrombocytopenia: A monocentric experience Blood 2014;124(21): - .
Review	Montagna M T, Lovero G, Borghi E, Amato G, Andreoni S, Campion L, Lo Cascio G, Lombardi G, Luzzaro F, Manso E, Mussap M, Pecile P, Perin S, Tangorra E, Tronci M, Iatta R, Morace G Candidemia in Intensive Care Unit: A nationwide prospective observational survey (GISIA-3 study) and review of the European literature from 2000 through 2013 Eur Rev Med Pharmacol Sci 2014;18(5):661-674.
Prospective Studies; Multicenter Study	Montagna MT, Lovero G, Coretti C, Martinelli D, Delia M, De Giglio O, Caira M, Puntillo F, D'Antonio D, Venditti M, Sambri V, Di Bernardo F, Barbui A, Lo Cascio G, Concia E, Mikulska M, Viscoli C, Maximova N, Candoni A, Oliveri S, Lombardi G, Pitzurra L, Sanguinetti M, Masciari R, Santantonio T, Andreoni S, Barchiesi F, Pecile P, Farina C, Viale P, Specchia G, Caggiano G, Pagano L SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patients Infection 2014;42(1):141-151.
Conference Abstract	Montillo M, O'Brien S, Tedeschi A, Hillmen P, Dearden C, Gill D, Brown JR, Barrientos JC, Mulligan S, Furman RR, Cymbalista F, Plascencia C, Chang S, Hsu E, James DF, Byrd JC Autoimmune hemolytic anemia and immune mediated thrombocytopenia in the phase III resonatetm study of ibrutinib vs ofatumumab in relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma, including a case report Blood 2014;124(21): - .
Conference Abstract	Montillo M, Rossi D, Motta M, Quaresmini G, Rossi M, Coscia M, Anastasia A, Rossini F, Cortellezzi A, Nador G, Scarfo L, Cairoli R, Frustaci AM, Dal Ceggio D, Picardi P, De Paoli L, Orlandi E, Rambaldi A, Morra E, Massaia M, Tedeschi A A phase II multi-center trial of pentostatin plus cyclophosphamide with ofatumumab (PCO) in older previously untreated chronic lymphocytic leukemia (CLL) patients Haematologica 2014;99(Suppl 1):61-62.
Clinical Trial; Multicenter Study	Montillo M, Tedeschi A, Gaidano G, Coscia M, Belsito Petrizzi V, Orlandi E, Cascavilla N, Ghia P, Motta M, Gallamini A, Frustaci A M, Rossi D, De Paoli L, Nichelatti M, Morra E, Massaia M Bendamustine and subcutaneous Alemtuzumab combination is an effective treatment in relapsed/refractory chronic lymphocytic leukemia patients Haematologica 2014; 99(9):e159-e161.
Conference Abstract	Mori S, Vagge E, Le Coutre P, Abruzzese E, Martino B, Pungolino E, Elena C, Pierri I, Assouline S, D'Emilio A, Gozzini A, Giraldo P, Stagno F, Iurlo A, Rizzo C, Fossati A, Kim DW, Pirola A, Petroccione A, Lodolo D'Oria A, Crivori P, Piazza R, Gambacorti Passerini C Age and digital-PCR analysis predict relapses of CML patients following programmed imatinib interruption in QRT-PCR negative chronic myeloid leukemia patients Haematologica 2014;99(Suppl 1):76- .

Risultati da 2921 a 2940 di 6391 totali

Precedente -

- Successiva

AZIENDA OSPEDALIERA OSPEDALE NIGUARDA CA' GRANDA | Piazza Ospedale Maggiore 3 | 20162 Milano | t. +39 02 6444.1 - f. +39 02 6420901 | CF e Partita IVA: 11390840152